Your browser doesn't support javascript.
loading
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
Kumar, Anita; Casulo, Carla; Advani, Ranjana H; Budde, Elizabeth; Barr, Paul M; Batlevi, Connie L; Caron, Philip; Constine, Louis S; Dandapani, Savita V; Drill, Esther; Drullinsky, Pamela; Friedberg, Jonathan W; Grieve, Clare; Hamilton, Audrey; Hamlin, Paul A; Hoppe, Richard T; Horwitz, Steven M; Joseph, Ashlee; Khan, Niloufer; Laraque, Leana; Matasar, Matthew J; Moskowitz, Alison J; Noy, Ariela; Palomba, Maria Lia; Schöder, Heiko; Straus, David J; Vemuri, Shreya; Yang, Joanna; Younes, Anas; Zelenetz, Andrew D; Yahalom, Joachim; Moskowitz, Craig H.
Affiliation
  • Kumar A; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Casulo C; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
  • Advani RH; Stanford Cancer Institute, Stanford University, Stanford, CA.
  • Budde E; City of Hope National Medical Center, Duarte, CA.
  • Barr PM; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
  • Batlevi CL; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Caron P; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Constine LS; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
  • Dandapani SV; City of Hope National Medical Center, Duarte, CA.
  • Drill E; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Drullinsky P; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Friedberg JW; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
  • Grieve C; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hamilton A; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hamlin PA; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Hoppe RT; Stanford Cancer Institute, Stanford University, Stanford, CA.
  • Horwitz SM; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Joseph A; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Khan N; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Laraque L; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Matasar MJ; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Moskowitz AJ; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Noy A; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Schöder H; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Straus DJ; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Vemuri S; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Yang J; University of California San Francisco, San Francisco, CA.
  • Younes A; AstraZeneca US, Wilmington, DE.
  • Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Yahalom J; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Moskowitz CH; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.
J Clin Oncol ; 39(20): 2257-2265, 2021 07 10.
Article in En | MEDLINE | ID: mdl-33909449

Full text: 1 Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols / Chemoradiotherapy / Antineoplastic Agents, Immunological / Brentuximab Vedotin Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Clin Oncol Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols / Chemoradiotherapy / Antineoplastic Agents, Immunological / Brentuximab Vedotin Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: J Clin Oncol Year: 2021 Type: Article